EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Inflammopharmacology

Description
Experimental and Therapeutic Studies

 

Status
active
Indexing
Academic OneFile, Academic Search, Biological Abstracts, BIOSIS Previews, Chemical Abstracts Service (CAS), ChemWeb, CSA/Proquest, Current Abstracts, Current Awareness in Biological Sciences (CABS), Elsevier Biobase, EMBASE, Gale, Google Scholar, Health Reference Center Academic, IBIDS, INPHARMA, OCLC, PubMed/Medline, Science & Technology Collection, SCOPUS, Summon by Serial Solutions, TOC Premier
Subject

Source type
Journal
Publisher
ISBN ISSN
0925-4692
E ISSN
1568-5608
First volume
1
Last volume
20+
Publish city
Basel
Homepage
Description

InflammoPharmacology is the official publication of the Gastrointestinal Section of the International Union of Pharmacology (IUPHAR) and the Hungarian Society for Experimental and clinical Pharmacology (HSECP).

InflammoPharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, and arthritic conditions.



Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )